Compare IBRX & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | FCFS |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 8.4B |
| IPO Year | 2015 | 1996 |
| Metric | IBRX | FCFS |
|---|---|---|
| Price | $7.26 | $200.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $12.57 | ★ $191.00 |
| AVG Volume (30 Days) | ★ 22.2M | 306.3K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | ★ 38.71 | 29.49 |
| EPS | N/A | ★ 7.42 |
| Revenue | $113,288,000.00 | ★ $3,661,043,000.00 |
| Revenue This Year | $88.59 | $16.20 |
| Revenue Next Year | $131.15 | $8.35 |
| P/E Ratio | ★ N/A | $26.98 |
| Revenue Growth | ★ 668.31 | 8.04 |
| 52 Week Low | $1.83 | $116.66 |
| 52 Week High | $12.43 | $202.25 |
| Indicator | IBRX | FCFS |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 62.75 |
| Support Level | $5.89 | $178.78 |
| Resistance Level | $8.28 | N/A |
| Average True Range (ATR) | 0.94 | 6.58 |
| MACD | -0.21 | -0.26 |
| Stochastic Oscillator | 25.33 | 88.74 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.